Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innoveren Scientific Inc (CE) | IVRN | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0036 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0036 | 0.0036 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0003 - 1.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.0036 | USD |
Innoveren Scientific Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 661.35k | 59.02k | 453k | -10.3M | -14.45 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Innoveren Scientific (CE) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IVRN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.0036 | 0.0036 | 0.0036 | 0.0036 | 500 | 0.00 | 0.00% |
| 3 Months | 0.055 | 0.06 | 0.0003 | 0.0329532 | 173,767 | -0.0514 | -93.45% |
| 6 Months | 0.129 | 0.50 | 0.0003 | 0.0427828 | 105,732 | -0.1254 | -97.21% |
| 1 Year | 1.00 | 1.50 | 0.0003 | 0.0695982 | 68,247 | -0.9964 | -99.64% |
| 3 Years | 1.00 | 1.50 | 0.0003 | 0.0695982 | 68,247 | -0.9964 | -99.64% |
| 5 Years | 1.00 | 1.50 | 0.0003 | 0.0695982 | 68,247 | -0.9964 | -99.64% |
Innoveren Scientific (CE) Description
| H-CYTE is a hybrid-biopharmaceutical company dedicated to developing and delivering a novel portfolio of new diagnostics, therapeutics, and medical devices from concept to commercialization. |
